Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-247540
Filing Date
2024-10-30
Accepted
2024-10-30 16:05:57
Documents
1
Group Members
J. LUTHER KING, JR.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d900099dsc13ga.htm SC 13G/A 49779
  Complete submission text file 0001193125-24-247540.txt   51442
Mailing Address 301 COMMERCE SUITE 1600 FORT WORTH TX 76102
Business Address 301 COMMERCE SUITE 1600 FORT WORTH TX 76102 8173323235
KING LUTHER CAPITAL MANAGEMENT CORP (Filed by) CIK: 0000310051 (see all company filings)

EIN.: 75163030 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Subject) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90193 | Film No.: 241410285
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)